The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.
The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.
The ETF enables investors to access high growth potential through companies at the leading edge of a structural trend affecting the global health care industry.
The ETF's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.
In a single trade, the ETF delivers access to dozens of companies with high exposure to the telemedicine & digital health theme.
Presently, Global X UCITS ETFs are best accessed either in consultation with a financial advisor or a broker qualified to purchase stocks, ETFs and other securities on behalf of clients. Brokerage and other fees may apply. Global X does not make any recommendations or endorsements.
| Primary Ticker | EDOC |
| Primary ISIN | IE00BLR6QB00 |
| Inception Date | 17 Dec 2020 |
| Bloomberg Index Ticker | SOLEDOC |
| Index Provider | Solactive AG |
| Management Style | Physical - Full Replication |
| Management Company | Global X Management Company |
| Custodian | BBH |
| Domicile | Ireland |
| Fund AUM | $13,272,449.08 |
| Number of Holdings | 39 |
| Total Expense Ratio | 0.68% |
| Ongoing Charges | 0.68% |
| Distribution Frequency | Semi-Annually |
| UCITS Compliant | Yes |
| ISA Eligibility | Yes |
| SIPP Available | Yes |
| UK Reporting Status | Yes |
Societe Generale SA, Goldenberg Hehmeyer LLP, Jane Street Financial Ltd, Mirae Asset Securites UK Ltd, Flow Traders BV
Ireland, Finland, Germany, Netherlands, Norway, Spain, UK
| Exchange | Trading Currency |
Ticker | Listing Date |
SEDOL | Net Asset Value (NAV) |
Shares Outstanding |
Net Assets |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | USD | EDOC LN | 18 Dec 2020 | BLR6Q54 | $14.91 (-4.24%) | 780,000 | $11,632,052.40 |
| Deutsche Börse Xetra | EUR | DDOC GY | 04 Feb 2021 | BLR6Q76 |
| Exchange | Trading Currency |
Ticker | Listing Date |
SEDOL | Net Asset Value (NAV) |
Shares Outstanding |
Net Assets |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | GBP | EDOG LN | 18 Dec 2020 | BLR6Q98 | $14.91 (-4.24%) | 110,000 | $1,640,396.68 |
As of 28 Feb 2021 |
Fund | Index | Relative |
|---|---|---|---|
| Last 12 Months | -- | -- | -- |
Returns not available as there is less than 12 months of performance history.
| % of Net Assets | ||
|---|---|---|
| Health Care | 59.5 | |
| Information Technology | 30.7 | |
| Communication Services | 3.9 | |
| Industrials | 3.7 | |
| Financials | 1.1 | |
| Materials | 0.9 | |
| Other/Cash | 0.2 | |
Source: AltaVista Research, LLC
| % of Net Assets | ||
|---|---|---|
| United States | 82.6 | |
| Hong Kong | 4.2 | |
| Japan | 3.9 | |
| China | 3.7 | |
| Netherlands | 2.6 | |
| Germany | 1.8 | |
| Australia | 1.1 | |
| Other/Cash | 0.1 | |
Source: AltaVista Research, LLC
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 4.76 | NUAN | NUANCE COMMUNICATIONS INC | 2402121 | 42.08 | 15,016 | 631,873.28 |
| 4.73 | ILMN | ILLUMINA INC | 2613990 | 399.61 | 1,572 | 628,186.92 |
| 4.56 | 241 HK | ALIBABA HEALTH | BRXVS60 | 3.42 | 177,300 | 605,560.10 |
| 4.39 | GH | GUARDANT HEALTH INC | BFXC911 | 133.15 | 4,376 | 582,664.40 |
| 4.24 | OMCL | OMNICELL INC | 2789523 | 122.02 | 4,610 | 562,512.20 |
| 4.23 | CHNG | CHANGE HEALTHCARE INC | BK5CVS5 | 22.45 | 25,015 | 561,586.75 |
| 4.21 | LH | LABORATORY CP | 2586122 | 234.90 | 2,379 | 558,827.10 |
| 4.13 | A | AGILENT TECHNOLOGIES INC | 2520153 | 114.99 | 4,771 | 548,617.29 |
| 4.04 | 2413 JP | M3 INC | B02K2M3 | 75.62 | 7,093 | 536,391.64 |
| 3.95 | NEO | NEOGENOMICS INC | 2598246 | 45.19 | 11,590 | 523,752.10 |
| Holdings are subject to change. | ||||||
The value of an investment in ETFs may go down as well as up and past performance is not a reliable indicator of future performance.
Trading in ETFs may not be suitable for all types of investors as they carry a high degree of risk. You may lose all of your initial investment. Only speculate with money you can afford to lose. Changes in exchange rates may also cause your investment to go up or down in value. Tax treatment depends on the individual circumstances of each client and may be subject to change in the future. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice. Investors should refer to the section entitled “Risk Factors” in the relevant prospectus for further details of these and other risks associated with an investment in the securities offered by the Issuer.